122 related articles for article (PubMed ID: 31188489)
1. An antibody to Notch3 reverses the skeletal phenotype of lateral meningocele syndrome in male mice.
Yu J; Siebel CW; Schilling L; Canalis E
J Cell Physiol; 2020 Jan; 235(1):210-220. PubMed ID: 31188489
[TBL] [Abstract][Full Text] [Related]
2. The lateral meningocele syndrome mutation causes marked osteopenia in mice.
Canalis E; Yu J; Schilling L; Yee SP; Zanotti S
J Biol Chem; 2018 Sep; 293(36):14165-14177. PubMed ID: 30042232
[TBL] [Abstract][Full Text] [Related]
3. Antisense oligonucleotides targeting
Canalis E; Grossman TR; Carrer M; Schilling L; Yu J
J Biol Chem; 2020 Mar; 295(12):3952-3964. PubMed ID: 31992595
[TBL] [Abstract][Full Text] [Related]
4. An Antibody to Notch2 Reverses the Osteopenic Phenotype of Hajdu-Cheney Mutant Male Mice.
Canalis E; Sanjay A; Yu J; Zanotti S
Endocrinology; 2017 Apr; 158(4):730-742. PubMed ID: 28323963
[TBL] [Abstract][Full Text] [Related]
5. Use of antisense oligonucleotides to target Notch3 in skeletal cells.
Canalis E; Carrer M; Eller T; Schilling L; Yu J
PLoS One; 2022; 17(5):e0268225. PubMed ID: 35536858
[TBL] [Abstract][Full Text] [Related]
6. Truncating mutations in the last exon of NOTCH3 cause lateral meningocele syndrome.
Gripp KW; Robbins KM; Sobreira NL; Witmer PD; Bird LM; Avela K; Makitie O; Alves D; Hogue JS; Zackai EH; Doheny KF; Stabley DL; Sol-Church K
Am J Med Genet A; 2015 Feb; 167A(2):271-81. PubMed ID: 25394726
[TBL] [Abstract][Full Text] [Related]
7. Hairy and enhancer of split 1 is a primary effector of NOTCH2 signaling and induces osteoclast differentiation and function.
Yu J; Schilling L; Eller T; Canalis E
J Biol Chem; 2021 Dec; 297(6):101376. PubMed ID: 34742737
[TBL] [Abstract][Full Text] [Related]
8. NOTCH2 promotes osteoclast maturation and metabolism and modulates the transcriptome profile during osteoclastogenesis.
Canalis E; Schilling L; Yu J; Denker E
J Biol Chem; 2024 Feb; 300(2):105613. PubMed ID: 38159855
[TBL] [Abstract][Full Text] [Related]
9. The Hajdu Cheney mutation sensitizes mice to the osteolytic actions of tumor necrosis factor α.
Yu J; Canalis E
J Biol Chem; 2019 Sep; 294(39):14203-14214. PubMed ID: 31371452
[TBL] [Abstract][Full Text] [Related]
10. Lateral meningocele (Lehman) syndrome: A child with a novel NOTCH3 mutation.
Ejaz R; Qin W; Huang L; Blaser S; Tetreault M; Hartley T; Boycott KM; Carter MT;
Am J Med Genet A; 2016 Apr; 170A(4):1070-5. PubMed ID: 26754023
[TBL] [Abstract][Full Text] [Related]
11. Induction of a NOTCH3 Lehman syndrome mutation in osteocytes causes osteopenia in male C57BL/6J mice.
Canalis E; Yee SP; Economides AN; Schilling L; Yu J
Bone; 2022 Sep; 162():116476. PubMed ID: 35760307
[TBL] [Abstract][Full Text] [Related]
12. Antisense oligonucleotides targeting a NOTCH3 mutation in male mice ameliorate the cortical osteopenia of lateral meningocele syndrome.
Canalis E; Mocarska M; Schilling L; Jafar-Nejad P; Carrer M
Bone; 2023 Dec; 177():116898. PubMed ID: 37704069
[TBL] [Abstract][Full Text] [Related]
13. Mice harboring a Hajdu Cheney Syndrome mutation are sensitized to osteoarthritis.
Zanotti S; Yu J; Bridgewater D; Wolf JM; Canalis E
Bone; 2018 Sep; 114():198-205. PubMed ID: 29940267
[TBL] [Abstract][Full Text] [Related]
14. The Skeleton of Lateral Meningocele Syndrome.
Canalis E
Front Genet; 2020; 11():620334. PubMed ID: 33519922
[TBL] [Abstract][Full Text] [Related]
15. Expansion of the phenotype of lateral meningocele syndrome.
Cappuccio G; Apuzzo D; Alagia M; Torella A; Pinelli M; Franco B; Corrado B; Del Giudice E; D'Amico A; Nigro V; ; Brunetti-Pierri N
Am J Med Genet A; 2020 May; 182(5):1259-1262. PubMed ID: 32141180
[TBL] [Abstract][Full Text] [Related]
16. Neurosurgical Management of Lateral Meningocele Syndrome: A Clinical Update for the Pediatric Neurosurgeon.
Cuoco JA; Klein BJ; Busch CM; Gosnell HL; Kar A; Marvin EA; Apfel LS
Pediatr Neurosurg; 2020; 55(1):2-11. PubMed ID: 31838470
[TBL] [Abstract][Full Text] [Related]
17. Activation of Notch3 in osteoblasts/osteocytes causes compartment-specific changes in bone remodeling.
Canalis E; Zanotti S; Schilling L; Eller T; Yu J
J Biol Chem; 2021; 296():100583. PubMed ID: 33774049
[TBL] [Abstract][Full Text] [Related]
18. Characterization of activating mutations of NOTCH3 in T-cell acute lymphoblastic leukemia and anti-leukemic activity of NOTCH3 inhibitory antibodies.
Bernasconi-Elias P; Hu T; Jenkins D; Firestone B; Gans S; Kurth E; Capodieci P; Deplazes-Lauber J; Petropoulos K; Thiel P; Ponsel D; Hee Choi S; LeMotte P; London A; Goetcshkes M; Nolin E; Jones MD; Slocum K; Kluk MJ; Weinstock DM; Christodoulou A; Weinberg O; Jaehrling J; Ettenberg SA; Buckler A; Blacklow SC; Aster JC; Fryer CJ
Oncogene; 2016 Nov; 35(47):6077-6086. PubMed ID: 27157619
[TBL] [Abstract][Full Text] [Related]
19. Induction of the Hajdu-Cheney Syndrome Mutation in CD19 B Cells in Mice Alters B-Cell Allocation but Not Skeletal Homeostasis.
Yu J; Zanotti S; Schilling L; Schoenherr C; Economides AN; Sanjay A; Canalis E
Am J Pathol; 2018 Jun; 188(6):1430-1446. PubMed ID: 29545197
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
